• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Scroll to next section Scroll to next section
Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share by Mail

Non-Sponsored Content


INFECTIOUS DISEASE

Covid-19患者的臨床特徵

分析：Dr Siddharth Sridhar，臨床微生物及感染學專科醫生 | 翻譯：Helen YC LAW, MediPaper Medical Communications Ltd.| 更新：2020年2月26日  | In: COVID-19, Therapeutic Areas, Critical Care Medicine, SARS-CoV2, Pneumonia, Infectious Disease

Article Keywords

pneumonia, China, WARS, SARS-CoV-2, 2019-nCoV, corona virus, COVID-19

English Version

在這裡，我綜合了21個病例報告、病例系列和描述性研究（包括鐘南山在medrxiv發表的大型群組），總結了Covid-19患者的臨床特徵。目前有2198名患者的人口統計學特徵和1689名患者的臨床特徵。

  1. 大多數受感染的Covid-19患者，胸肺放射影像會出現異常。通常會發燒或咳嗽，但現在無症狀的感染者也多見。
  2. 兒童出現症狀的病例較少見，而且症狀通常輕微。
  3. 每5人中約有1人發展為嚴重病例（高氧氣需求量、呼吸機使用、需接受深切治療），這些嚴重病例的患者往往是本身有其他疾病的長者。
  4. 總死亡率為5.2％。然而，該群組中的許多患者在論文發表時尚未出院，因此他們的最終結果尚未知悉。

YOU MAY ALSO LIKE

content continues below


YOU MAY ALSO LIKE

MPR-FOS-2023019 HKMA HKSID Launch 4 MAR

Achieving the Best Outcomes under COVID-19 Endemicity

https://medi-paper.com/wp-content/uploads/2023/05/MPR-FOS-2023019-HKMA-HKSID-Launch-4-MAR-scaled.jpg 1366 2560 Jeffrey Martin https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Jeffrey Martin2023-05-17 12:25:412023-05-31 12:39:03Achieving the Best Outcomes under COVID-19 Endemicity
INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

https://medi-paper.com/wp-content/uploads/2023/01/INACTIVATED-AND-mRNA-COVID-19-VACCINES-IN-PATIENTS-WITH-AUTOIMMUNE-RHEUMATIC-DISEASES-–-A-CITY-OF-TWO-TALES.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-30 10:47:542023-02-02 16:50:53Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales
Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

https://medi-paper.com/wp-content/uploads/2023/01/Late-but-sinister-post-COVID-19-conditions_new-onset-rheumatic-diseases.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 12:18:572023-03-08 12:48:36Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases
COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

https://medi-paper.com/wp-content/uploads/2023/01/COVID-19-Infection-and-Subfertility-A-Subtle-and-Debatable-Complication.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 11:32:342023-01-19 18:28:49COVID-19 Infection and Subfertility: A Subtle and Debatable Complication
Previous Previous Previous Next Next Next
MPR-FOS-2023019 HKMA HKSID Launch 4 MAR
17 May 2023

Achieving the Best Outcomes under COVID-19 Endemicity

INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES
30 January 2023

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

Disclaimer

This article is not medical advice. Patients should seek personal assessment by a licenced specialist. Physicians are recommended to read the full publication(s) as cited in the article before making medical decisions. This article does not supersede nor replace the published article(s).

© Copyright 2020 Dr Sridhar Siddharth – Covid-19患者的臨床特徵

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share by Mail

YOU MAY ALSO LIKE

MPR-FOS-2023019 HKMA HKSID Launch 4 MAR

Achieving the Best Outcomes under COVID-19 Endemicity

https://medi-paper.com/wp-content/uploads/2023/05/MPR-FOS-2023019-HKMA-HKSID-Launch-4-MAR-scaled.jpg 1366 2560 Jeffrey Martin https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Jeffrey Martin2023-05-17 12:25:412023-05-31 12:39:03Achieving the Best Outcomes under COVID-19 Endemicity
INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

https://medi-paper.com/wp-content/uploads/2023/01/INACTIVATED-AND-mRNA-COVID-19-VACCINES-IN-PATIENTS-WITH-AUTOIMMUNE-RHEUMATIC-DISEASES-–-A-CITY-OF-TWO-TALES.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-30 10:47:542023-02-02 16:50:53Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales
Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

https://medi-paper.com/wp-content/uploads/2023/01/Late-but-sinister-post-COVID-19-conditions_new-onset-rheumatic-diseases.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 12:18:572023-03-08 12:48:36Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases
COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

https://medi-paper.com/wp-content/uploads/2023/01/COVID-19-Infection-and-Subfertility-A-Subtle-and-Debatable-Complication.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 11:32:342023-01-19 18:28:49COVID-19 Infection and Subfertility: A Subtle and Debatable Complication
COVID-19 vaccine booster strategy: Striving for the best

COVID-19 VACCINE BOOSTER STRATEGY: STRIVING FOR THE BEST

https://medi-paper.com/wp-content/uploads/2023/01/COVID-19-vaccine-booster-strategy_Striving-for-the-best.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-16 10:03:242024-04-10 14:28:47COVID-19 VACCINE BOOSTER STRATEGY: STRIVING FOR THE BEST
Protection is Never Premature_Maternal COVID-19 Infection and Adverse Perinatal Outcomes

Protection is Never Premature: Maternal COVID-19 Infection is Associated with Adverse Perinatal Outcomes

https://medi-paper.com/wp-content/uploads/2022/12/Protection-is-Never-Premature_Maternal-COVID-19-Infection-and-Adverse-Perinatal-Outcomes.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-12-05 11:58:442023-03-08 12:42:36Protection is Never Premature: Maternal COVID-19 Infection is Associated with Adverse Perinatal Outcomes

Updates on COVID-19 Vaccine Booster in Omicron Era

https://medi-paper.com/wp-content/uploads/2022/12/Updates-on-COVID-19-Vaccine-Booster-in-Omicron-Era_A.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-12-05 10:59:142022-12-06 15:49:40Updates on COVID-19 Vaccine Booster in Omicron Era
Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents

Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents

https://medi-paper.com/wp-content/uploads/2022/11/Should-your-child-receive-covid-19-vaccination.-Risk-benefit-analyses-in-infants-children-and-adolescents.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-11-07 02:14:052022-11-09 03:12:41Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents
At the Heart of the Discussion: COVID-19 Cardiovascular Complications in the Pregnant Women

At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women

https://medi-paper.com/wp-content/uploads/2022/11/At-the-Heart-of-the-Discussion.-COVID-19-Cardiovascular-Complications-in-the-Pregnant-Women.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-11-06 07:53:422022-11-07 08:56:16At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women
Covid-19 vaccination safety and effectiveness for pregnant and lactating women

Covid-19 vaccination safety and effectiveness for pregnant and lactating women

https://medi-paper.com/wp-content/uploads/2022/10/Covid-19-vaccination-safety-and-effectiveness-for-pregnant-and-lactating-women.jpg 1024 1918 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2022-10-25 06:03:462022-10-25 07:52:49Covid-19 vaccination safety and effectiveness for pregnant and lactating women
Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients

HKMA CME Live Lecture: Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients

https://medi-paper.com/wp-content/uploads/2022/08/Dr-Ho-SO-–-Vaccination-Safety-and-Effectiveness-in-Immunocompromised-Patients.jpg 1024 1918 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2022-08-26 05:25:062022-09-19 11:29:45HKMA CME Live Lecture: Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients
Vaccination versus Active Infection_A Comparison of the Cardiovascular Risks

Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks

https://medi-paper.com/wp-content/uploads/2022/08/Vaccination-versus-Active-Infection_A-Comparison-of-the-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 03:30:452022-08-30 10:51:31Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks
Common Respiratory Viruses and Their Associated Cardiovascular Risks

Common Respiratory Viruses and Their Associated Cardiovascular Risks

https://medi-paper.com/wp-content/uploads/2022/08/Common-Respiratory-Viruses-and-Their-Associated-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 02:02:012022-08-30 10:51:35Common Respiratory Viruses and Their Associated Cardiovascular Risks
Strategy for COVID-19 vaccination: Disease control, elimination or eradication

Strategy for COVID-19 vaccination: Disease control, elimination or eradication?

https://medi-paper.com/wp-content/uploads/2022/07/Strategy-for-COVID-19-vaccination-Disease-control-elimination-or-eradication.jpg 1024 1918 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2022-07-12 07:00:302022-07-13 05:40:30Strategy for COVID-19 vaccination: Disease control, elimination or eradication?
SARS-CoV-2 evolution in the COVID-19 era: Three years and counting

SARS-CoV-2 evolution in the COVID-19 era: Three years and counting

https://medi-paper.com/wp-content/uploads/2022/07/SARS-CoV-2-evolution-in-the-COVID-19-era-Three-years-and-counting.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-07-08 08:39:322022-07-12 09:20:40SARS-CoV-2 evolution in the COVID-19 era: Three years and counting
UK statistics suggest COVID-19 variant types as “long COVID” progression predictors

UK statistics suggest COVID-19 variant types as “long COVID” progression predictors

https://medi-paper.com/wp-content/uploads/2022/07/UK-statistics-suggest-COVID-19-variant-types-as-long-COVID-progression-predictors.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-07-08 08:01:272022-07-12 09:10:35UK statistics suggest COVID-19 variant types as “long COVID” progression predictors
COVID-19 ANTIVIRAL TREATMENT AND BOOSTER VACCINE EFFECTIVENESS

COVID-19 Antiviral Treatment and Booster Vaccine Effectiveness

https://medi-paper.com/wp-content/uploads/2022/06/MPR-FOS-2022003_1918x1024.jpg 1024 1918 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2022-06-21 02:46:572022-07-13 05:48:31COVID-19 Antiviral Treatment and Booster Vaccine Effectiveness
Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme

Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme

https://medi-paper.com/wp-content/uploads/2022/06/HIV-cover-photo.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-06-20 07:49:562022-06-28 11:33:57Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme
An Overview of the South African COVID-19 Subvariant Outbreak: How Serious is It?

An Overview of the South African COVID-19 Subvariant Outbreak

https://medi-paper.com/wp-content/uploads/2022/06/cover-photo-1918x1024-1.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-06-17 02:30:592022-06-28 11:55:35An Overview of the South African COVID-19 Subvariant Outbreak
COVID-19 Vaccinations in Adolescents and Children

COVID-19 Vaccinations in Adolescents and Children

https://medi-paper.com/wp-content/uploads/2022/05/COVID-19-Vaccinations-in-Adolescents-and-Children-scaled.jpg 1367 2560 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-05-30 07:01:232022-07-13 05:54:09COVID-19 Vaccinations in Adolescents and Children
Monkeypox Virus: How Likely is a Local Outbreak?

Monkeypox Virus: How Likely is a Local Outbreak?

https://medi-paper.com/wp-content/uploads/2022/05/Monkeypox-Virus_How-Likely-is-a-Local-Outbreak-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-30 05:32:332022-05-31 05:58:12Monkeypox Virus: How Likely is a Local Outbreak?
Local Updates on COVID-19 Prevention and Treatment

Local Updates on COVID-19 Prevention and Treatment

https://medi-paper.com/wp-content/uploads/2022/05/Local-Updates-on-COVID-19-Prevention-and-Treatment-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-30 04:49:162022-05-31 11:25:18Local Updates on COVID-19 Prevention and Treatment
Tolerability of COVID-19 vaccines in patients with cancer

Tolerability of COVID-19 vaccines in patients with cancer

https://medi-paper.com/wp-content/uploads/2022/05/Tolerability-of-COVID-19-vaccines-in-patients-with-cancer-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-17 02:20:592022-05-17 05:46:03Tolerability of COVID-19 vaccines in patients with cancer
US and Chinese Studies Suggest More Severe Outcomes in COVID-19 Patients with Cancer

More Severe Outcomes in COVID-19 Patients with Cancer

https://medi-paper.com/wp-content/uploads/2022/05/US-and-Chinese-Studies-Suggest-More-Severe-Outcomes-in-COVID-19-Patients-with-Cancer-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-16 08:12:092022-05-17 05:46:03More Severe Outcomes in COVID-19 Patients with Cancer
COVID-19 vaccination safety and effectiveness for pregnant and lactating women

COVID-19 vaccination safety and effectiveness for pregnant and lactating women

https://medi-paper.com/wp-content/uploads/2022/05/COVID-19-vaccination-safety-and-effectiveness-for-pregnant-and-lactating-women-scaled.jpg 1367 2560 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-05-03 02:34:242022-05-17 05:46:03COVID-19 vaccination safety and effectiveness for pregnant and lactating women
Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

https://medi-paper.com/wp-content/uploads/2022/04/Gut-Microbiome-Predictor-for-COVID-19-Vaccine-Response-and-Safety-CZ02-and-BNT162b2-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-04-29 10:30:502022-05-17 05:46:03Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)
US Study Suggests A Lesser-known COVID-19 Complication Diabetes Mellitus

US Study Suggests A Lesser-known COVID-19 Complication: Diabetes Mellitus

https://medi-paper.com/wp-content/uploads/2022/04/US-Study-Suggests-A-Lesser-known-COVID-19-Complication-Diabetes-Mellitus-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-04-29 05:47:272022-05-17 05:46:03US Study Suggests A Lesser-known COVID-19 Complication: Diabetes Mellitus
Vaccination Strategies and Management Against Omicron Outbreak

Vaccination Strategies and Management Against Omicron Outbreak

https://medi-paper.com/wp-content/uploads/2022/03/Vaccination-Strategies-and-Management-Against-Omicron-Outbreak.png 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-04-01 03:37:202022-05-17 05:46:03Vaccination Strategies and Management Against Omicron Outbreak
UK study_Infected adolescents are at higher risk of long COVID symptoms

UK study: Infected adolescents are at higher risk of long COVID symptoms

https://medi-paper.com/wp-content/uploads/2022/03/UK-study_Infected-adolescents-are-at-higher-risk-of-long-COVID-symptoms.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-03-01 07:20:182022-05-17 05:46:03UK study: Infected adolescents are at higher risk of long COVID symptoms
Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

https://medi-paper.com/wp-content/uploads/2022/02/Antiviral-Molnupiravir-Associated-with-Reduced-Risk-of-Hospitalisation-or-Death-in-COVID-19-Patients.jpg 1024 1918 Chloe FUNG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Chloe FUNG2022-02-28 07:41:092022-05-17 05:46:03Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

Anti-TNF Therapy Correlated with Better Outcomes in IBD Patients with COVID-19

https://medi-paper.com/wp-content/uploads/2021/12/Anti-TNF-Therapy-Correlated-with-Better-Outcomes-in-IBD-Patients-with-COVID-19.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-20 12:58:472022-05-17 05:46:03Anti-TNF Therapy Correlated with Better Outcomes in IBD Patients with COVID-19

The use of COVID-19 vaccines in children and adolescents

https://medi-paper.com/wp-content/uploads/2021/12/The-use-of-COVID-19-vaccines-in-children-and-adolescents.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-16 11:53:112022-05-17 05:46:03The use of COVID-19 vaccines in children and adolescents
HPV-immunisation-in-UK-lowers-the-incidence-of-cervical-cancer-and-CIN3

HPV immunisation in UK lowers the incidence of cervical cancer and CIN3

https://medi-paper.com/wp-content/uploads/2021/12/HPV-immunisation-in-UK-lowers-the-incidence-of-cervical-cancer-and-CIN3.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-06 16:33:152022-02-20 10:34:01HPV immunisation in UK lowers the incidence of cervical cancer and CIN3
Combination-therapy-with-a-novel-agent-albuvirtide-in-hospitalised-AIDs-patients

Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients

https://medi-paper.com/wp-content/uploads/2021/11/Combination-therapy-with-a-novel-agent-albuvirtide-in-hospitalised-AIDs-patients.jpg 1024 1917 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-11-03 23:59:572022-02-19 05:11:56Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients
Pfizer-BioNTech-COVID-19-Vaccine-for-Ages-5-to-11-Years

BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?

https://medi-paper.com/wp-content/uploads/2021/11/Pfizer-BioNTech-COVID-19-Vaccine-for-Ages-5-to-11-Years.jpg 1024 1917 Catalina FOK https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Catalina FOK2021-11-03 15:29:572022-07-13 05:55:25BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?
Gender-related-differences-in-safety

Gender-related differences in safety after switching to BIC/TAF/FTC

https://medi-paper.com/wp-content/uploads/2021/11/Gender-related-differences-in-safety.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-11-03 14:49:542022-02-20 10:58:03Gender-related differences in safety after switching to BIC/TAF/FTC
Effect-of-HIV-infection-on-growth-and-bone-density-in-peripubertal-children-under-antiretroviral-therapy

Effect of HIV infection on growth and bone density in peripubertal children under antiretroviral therapy

https://medi-paper.com/wp-content/uploads/2021/07/Effect-of-HIV-infection-on-growth-and-bone-density-in-peripubertal-children-under-antiretroviral-therapy.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-20 17:03:522022-02-23 07:54:14Effect of HIV infection on growth and bone density in peripubertal children under antiretroviral therapy
Safety-and-Immunogenicity-of-the-BNT162b2-mRNA-Covid-19-Vaccine-in-Patients-after-Allogeneic-HCT-or-CD19-based-CAR-T-therapy

Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CAR-T therapy

https://medi-paper.com/wp-content/uploads/2021/07/Safety-and-Immunogenicity-of-the-BNT162b2-mRNA-Covid-19-Vaccine-in-Patients-after-Allogeneic-HCT-or-CD19-based-CAR-T-therapy.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-20 16:38:402022-05-17 05:46:03Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CAR-T therapy
Efficacy-and-safety-of-HIV-fusion-inhibitor-albuvirtide-in-treatment-experienced-patients-from-phase-3-TALENT-study

Efficacy and safety of HIV fusion inhibitor albuvirtide in treatment experienced patients from phase 3 TALENT study

https://medi-paper.com/wp-content/uploads/2021/07/Efficacy-and-safety-of-HIV-fusion-inhibitor-albuvirtide-in-treatment-experienced-patients-from-phase-3-TALENT-study.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-15 15:04:522022-02-23 08:15:19Efficacy and safety of HIV fusion inhibitor albuvirtide in treatment experienced patients from phase 3 TALENT study
COVID-19-impacting-regular-patient-care-for-cardiovascular-diseases

COVID-19 impacting regular patient care for cardiovascular diseases

https://medi-paper.com/wp-content/uploads/2021/02/COVID-19-impacting-regular-patient-care-for-cardiovascular-diseases.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-17 11:52:282022-05-17 05:46:03COVID-19 impacting regular patient care for cardiovascular diseases
SARS-CoV-2-infection-in-children-and-an-increased-risk-of-thrombotic-microangiopathy

SARS-CoV-2 infection in children and an increased risk of thrombotic microangiopathy

https://medi-paper.com/wp-content/uploads/2021/02/SARS-CoV-2-infection-in-children-and-an-increased-risk-of-thrombotic-microangiopathy.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-10 15:41:562022-05-17 05:46:03SARS-CoV-2 infection in children and an increased risk of thrombotic microangiopathy
Toxic-vaccine-disinformation_有關疫苗的虛假信息

有關疫苗的虛假信息

https://medi-paper.com/wp-content/uploads/2021/01/Toxic-vaccine-disinformation_有關疫苗的虛假信息.jpg 1024 1819 Dr Siddharth Sridhar https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Dr Siddharth Sridhar2021-01-11 18:28:422022-05-17 05:46:04有關疫苗的虛假信息
Evidence-of-SARS-CoV2-in-heart-cells

Evidence of SARS-CoV2 in heart cells

https://medi-paper.com/wp-content/uploads/2020/09/Evidence-of-SARS-CoV2-in-heart-cells.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-22 10:19:272022-05-17 05:46:04Evidence of SARS-CoV2 in heart cells
triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia

Triple combination effective for hospital- and ventilator-acquired pneumonia

https://medi-paper.com/wp-content/uploads/2020/09/triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-10 11:04:232022-02-24 01:58:40Triple combination effective for hospital- and ventilator-acquired pneumonia
risk-of-thrombosis-with-sars-cov-2-infection

Risk of thrombosis with SARS-CoV-2 infection

https://medi-paper.com/wp-content/uploads/2020/08/risk-of-thrombosis-with-sars-cov-2-infection.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-27 16:33:072022-05-17 05:46:04Risk of thrombosis with SARS-CoV-2 infection
no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status

No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status

https://medi-paper.com/wp-content/uploads/2020/08/no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-25 10:15:352022-02-24 03:56:17No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status
residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance

Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance

https://medi-paper.com/wp-content/uploads/2020/08/residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 16:18:002022-02-24 03:58:03Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance
potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations

Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations

https://medi-paper.com/wp-content/uploads/2020/08/potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 15:28:132022-02-24 03:59:44Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations
updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society

Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society

https://medi-paper.com/wp-content/uploads/2020/08/updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 14:41:322022-02-24 04:10:20Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society
interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV

Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV

https://medi-paper.com/wp-content/uploads/2020/08/interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:44:162022-02-24 04:09:24Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV
comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis

Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis

https://medi-paper.com/wp-content/uploads/2020/08/comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:02:232022-02-24 04:14:25Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis
Carboplatin-plus-paclitaxel-to-be-the-new-standard-of-care-for-anal-cancer

Carboplatin plus paclitaxel to be the new standard of care for anal cancer

https://medi-paper.com/wp-content/uploads/2020/07/Carboplatin-plus-paclitaxel-to-be-the-new-standard-of-care-for-anal-cancer.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-07-10 17:24:482022-02-24 04:17:57Carboplatin plus paclitaxel to be the new standard of care for anal cancer
Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers-e1581490460128

Updated: Clinical characteristics of patients with COVID-19

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers-e1581490460128.webp 470 987 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-26 15:23:392022-05-17 05:46:03Updated: Clinical characteristics of patients with COVID-19
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-開始-結束

開始? 結束?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-開始-結束.webp 750 1000 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-22 23:07:372022-05-17 05:46:04開始? 結束?
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-in-Hong-Kong-the-end-of-the-beginning-

COVID-19 in Hong Kong: the end of the beginning?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-in-Hong-Kong-the-end-of-the-beginning-.jpg 760 1000 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-22 13:48:352022-05-17 05:46:03COVID-19 in Hong Kong: the end of the beginning?
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港，人們如何感染Covid-19

How do people get COVID-19 in Hong Kong

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港，人們如何感染Covid-19.webp 920 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-20 21:45:582022-05-17 05:46:03How do people get COVID-19 in Hong Kong
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港，人們如何感染Covid-19

在本港，人們如何感染Covid-19?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港，人們如何感染Covid-19.webp 920 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-20 21:45:452022-05-17 05:46:03在本港，人們如何感染Covid-19?
Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況

2019-nCoV – Summary of the situation in HK as of Feb 6, 2020

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-07 00:31:582022-02-24 07:57:172019-nCoV – Summary of the situation in HK as of Feb 6, 2020
Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況

2019-nCoV在本港的概況（截至2020年2月6日）

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-07 00:31:112022-02-24 08:01:172019-nCoV在本港的概況（截至2020年2月6日）
Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高

新型冠狀病毒(2019-nCoV)的傳染性有多高？

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-04 00:49:132022-02-24 08:03:13新型冠狀病毒(2019-nCoV)的傳染性有多高？
Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高

How infectious is novel coronavirus (2019-nCoV)

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-03 22:33:562022-02-24 08:04:46How infectious is novel coronavirus (2019-nCoV)
Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性

2019-nCoV: how stable are coronaviruses in the environment?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-02 19:45:432022-02-24 08:07:252019-nCoV: how stable are coronaviruses in the environment?
Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性

2019-nCoV: 冠狀病毒在環境中的穩定性

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-02 19:29:372022-02-24 08:09:022019-nCoV: 冠狀病毒在環境中的穩定性
Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection

Who gets severe novel coronavirus (2019-nCoV) infection?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-01 23:45:262022-02-24 08:10:40Who gets severe novel coronavirus (2019-nCoV) infection?
Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection

誰受到 2019-nCoV嚴重感染？

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-01 23:27:182022-02-24 08:15:19誰受到 2019-nCoV嚴重感染？
Previous Previous Previous Next Next Next
1 reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

© Copyright 2020 Dr Sridhar Siddharth – Covid-19患者的臨床特徵

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Link to: Updated: Clinical characteristics of patients with COVID-19 Link to: Updated: Clinical characteristics of patients with COVID-19 Updated: Clinical characteristics of patients with COVID-19Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers-e1581490460128 Link to: Second-line treatment of gastric cancer or cancer of the gastroesophegeal junction: a case study of ramucirumab in Hong Kong Link to: Second-line treatment of gastric cancer or cancer of the gastroesophegeal junction: a case study of ramucirumab in Hong Kong gastric-adenocarcinoma-ramucirumab-cyramza-pembrolizumab-nivolumab-trastuzumab-dmmr-msi-her2-vegf-vegfr-gastric-cancer-gej-gastroesophageal-junction-cancer-pd-1-pd-l1-eli-lilly-lillySecond-line treatment of gastric cancer or cancer of the gastroesophegeal junction:...
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only